Growth Through Acquisition Position the opportunity around the recent acquisition by Linus Health to expand end-to-end workflow capabilities. Highlight potential integration with their platform to reach more patients and providers managing cognitive decline.

Enterprise Collaboration Target large health systems and ACOs (e.g., Rainier Health Network) that sponsor dementia-specific care programs. Offer scalable digital therapeutics that complement existing cognitive care pathways and help reduce social isolation among members.

Evidence Based Advantage Leverage UCSF-originated trials and NIH-supported funding to demonstrate outcomes. Position as a proven, reimburseable digital therapeutic that improves physical performance and quality of life for patients with dementia and MCI.

Medicare Alignment Emphasize compatibility with Medicare plans and potential to enable plan-level cognitive care initiatives. Present pathways for reimbursement, pilot programs, and scaling opportunities within Medicare Advantage and Part D ecosystems.

Strategic Partnerships Explore collaborations with NIH, UCSF, and other research institutions to expand evidence, expand program offerings, and create joint go-to-market efforts that attract health plans seeking innovative dementia care solutions.